Progyny Inc
Gesloten
SectorGezondheidszorg
27.36 0.59
Overzicht
Wijziging aandelenprijs
24u
Min
26.79
Max
27.56
Inkomsten | 28M 52M |
|---|---|
Verkoop | 22M 351M |
K/W Sectorgemiddelde | 28.196 56.597 |
EPS | 0.34 |
Winstmarge | 14.917 |
Werknemers | 835 |
EBITDA | 5.9M 44M |
Volgende Winsten | 5 nov 2026 |
|---|
Marktkapitalisatie | -448M 2B |
|---|---|
Vorige openingsprijs | 26.77 |
Vorige sluitingsprijs | 27.36 |
Nieuwssentiment
By Acuity
40%
60%
112 / 339 Rangschikking in Healthcare
Progyny Inc Grafiek
Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.
Gerelateerd nieuws
Peer Vergelijking
Prijswijziging
Progyny Inc Prognose
Sentiment
By Acuity
112 / 339 Rangschikking in Gezondheidszorg
Nieuwssentiment
Bullish Bewijs
Volatiliteit
Onder gemiddelde
Nieuws Volume (RCV)
Onder gemiddelde
Financieel
Verkoop- en administratiekosten
Bedrijfskosten
Winst voor belastingen
Verkoop
Kosten van verkopen
Brutowinst op verkopen
Rente-uitgaven op schulden
EBITDA
Operationele winst
$
Over Progyny Inc
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.